Document Detail


Blockade of the renin-angiotensin system. Effect on mortality in patients with left ventricular systolic dysfunction.
MedLine Citation:
PMID:  8181019     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Blockade of the renin-angiotensin-aldosterone system (RAAS) has been shown to be effective in reducing morbidity and mortality in patients with symptomatic left ventricular dysfunction. Angiotensin converting enzyme inhibitors (ACE-I) should be administered to all patients with symptomatic left ventricular dysfunction unless contraindicated or not tolerated. Although ACE-Is are effective, there is reason to believe that further blockade of the RAAS by aldosterone antagonists and/or alternative means of blocking the RAAS by use of renin inhibitors or angiotensin II receptor blocking agents may have an important role in the future. The finding in the SOLVD and SAVE trials that ACE-Is are effective in reducing recurrent ischemic events in patients with left ventricular dysfunction also holds great promise for the future, not only for patients with left ventricular dysfunction but also as a possible secondary prevention of ischemic heart disease in patients without left ventricular dysfunction.
Authors:
B Pitt
Related Documents :
16901709 - Doxorubicin in experimental and clinical heart failure.
20333409 - Cardiac manifestation of the hypereosinophilic syndrome: new insights.
20795939 - Vitamin d biology in heart failure: molecular mechanisms and systematic review.
10442679 - Ischemic and nonischemic heart failure do not require different treatment strategies.
16283969 - Aldosterone antagonists in the treatment and prevention of heart failure.
20186069 - Diuretic therapy in heart failure: current controversies and new approaches for fluid r...
21894419 - Cardiac surgery and hypertension: a dangerous association that must be well known.
425879 - Predictive value of electrocardiographic patterns in localizing left ventricular asyner...
3156009 - Effects of global ischemia on the diastolic properties of the left ventricle in the con...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Cardiology clinics     Volume:  12     ISSN:  0733-8651     ISO Abbreviation:  Cardiol Clin     Publication Date:  1994 Feb 
Date Detail:
Created Date:  1994-06-14     Completed Date:  1994-06-14     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8300331     Medline TA:  Cardiol Clin     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  101-14     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin-Converting Enzyme Inhibitors / pharmacology,  therapeutic use*
Clinical Trials as Topic
Coronary Disease / prevention & control
Heart Failure / drug therapy*,  mortality,  physiopathology*
Humans
Renin-Angiotensin System / drug effects*
Ventricular Function, Left / drug effects*
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevalence and prognosis of heart failure.
Next Document:  Ventricular arrhythmias in heart failure: to treat or not to treat?